ŌNŌCOR signs an exclusive US distribution agreement with B. Braun Interventional Systems PHILADELPHIA, July 17, 2023 (GLOBE NEWSWIRE) -- ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other facilitating technologies for the modern-day...

First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Embolized Leadless Pacemaker from the Right Pulmonary Artery PHILADELPHIA, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary...

Large Atrial Thrombus Percutaneously Removed Using the ŌNŌ Retrieval System ŌNŌCOR Reports First-In-Human Use for Removal of an Atrial Blood Clot PHILADELPHIA, Aug. 25, 2022 (GLOBE NEWSWIRE) -- ŌNŌCOR LLC announced the use of the ŌNŌ endovascular retrieval system to remove a large central-line-associated thrombus from the right atrium in a...

ŌNŌCOR Reports First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Intracardiac Tumor PHILADELPHIA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- ŌNŌCOR LLC is excited to announce the first-in-human use of the ŌNŌ endovascular retrieval system for removal of an intracardiac tumor. Intracardiac...

ŌNŌCOR Receives FDA Clearance for Novel Endovascular Retrieval Technology PHILADELPHIA, May 25, 2022 (GLOBE NEWSWIRE) -- ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food and Drug Administration (FDA) clearance for...